Jan Blaakær

Medicine & Life Sciences

1. Ovarian Neoplasms 100%
2. Ovarian Epithelial Carcinoma 56%
3. Uterine Cervical Neoplasms 49%
4. Denmark 33%
5. Neoplasms 32%
6. Hysterectomy 22%
7. Early Detection of Cancer 21%
8. Survival 19%
9. tetranectin 19%
10. Single Nucleotide Polymorphism 18%
11. Papillomavirus Infections 15%
12. Pelvic Organ Prolapse 14%
13. Vaccination 14%
14. Cohort Studies 14%
15. Case-Control Studies 12%
16. Colposcopy 12%
17. Confidence Intervals 12%
18. Gynecology 10%
19. Uterine Cervical Dysplasia 9%
20. Cell Biology 8%
21. Papillomaviridae 8%
22. Recurrence 8%
23. Tanzania 8%
24. Serum 8%
25. Cytoreduction Surgical Procedures 8%
26. Population 7%
27. Odds Ratio 7%
28. Endometriosis 7%
29. Breast Neoplasms 7%
30. Carcinoma 7%
31. Systematic Reviews 6%
32. Genotype 6%
33. Cross-Sectional Studies 6%
34. Databases 6%
35. Therapeutics 6%
36. Incidence 6%
37. Genes 6%
38. Scandinavian and Nordic Countries 6%
39. Oral Contraceptives 6%
40. General Practitioners 6%
41. Induced Hyperthermia 5%
42. Biopsy 5%
43. Pelvic Inflammatory Disease 5%
44. Alleles 5%
45. Logistic Models 5%
46. Cervix Uteri 5%
47. Guidelines 5%
48. Genome-Wide Association Study 5%
49. Proteins 5%
50. Endometrial Neoplasms 5%